About this trial
Last updated 4 years ago
Study ID
VBP-245-WART2A
Status
Unknown status
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
8+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 4 years ago
What is this trial about?
This is a multi-center, randomized, double-blind, placebo-controlled phase 2 study in
subjects 8 years of age and older who present with verruca vulgaris (common warts) and desire
treatment. Subjects may have up to a total of 6 common warts located on their trunk or
extremities that will be treated with study medication and followed throughout the study
protocol therapy. All warts will be treated two times per day (BID) for12 weeks.
Approximately 90 subjects will be enrolled in this study.
What are the participation requirements?
Inclusion Criteria
- Subject is able to comprehend and is willing to sign an informed consent/assent for participation in this study.
- Male or female ≥ 8 years old.
- Subject has a clinical diagnosis of verruca vulgaris (common warts).
- Subject has up to 6 warts located on the trunk or extremities
Exclusion Criteria
- Subject has clinically atypical warts on the trunk or extremities.
- Subject is immunocompromised (e.g., due to chemotherapy, systemic steroids, genetic immunodeficiency, transplant status, etc.)
- Subject has periungual, subungual, genital, anal, mosaic, plantar, flat, or filiform wart identified as a wart for study treatment.